1. Tasian, Sarah K, Loh, Mignon L, Hunger, Stephen P. 2017. Philadelphia chromosome-like acute lymphoblastic leukemia. In Blood, 130, 2064-2072. doi:10.1182/blood-2017-06-743252. https://pubmed.ncbi.nlm.nih.gov/28972016/
2. Jain, Sarika, Abraham, Anu. 2019. BCR-ABL1-like B-Acute Lymphoblastic Leukemia/Lymphoma: A Comprehensive Review. In Archives of pathology & laboratory medicine, 144, 150-155. doi:10.5858/arpa.2019-0194-RA. https://pubmed.ncbi.nlm.nih.gov/31644323/
3. Roberts, Kathryn G, Li, Yongjin, Payne-Turner, Debbie, Zhang, Jinghui, Mullighan, Charles G. . Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. In The New England journal of medicine, 371, 1005-15. doi:10.1056/NEJMoa1403088. https://pubmed.ncbi.nlm.nih.gov/25207766/
4. Reshmi, Shalini C, Harvey, Richard C, Roberts, Kathryn G, Gastier-Foster, Julie M, Hunger, Stephen P. 2017. Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group. In Blood, 129, 3352-3361. doi:10.1182/blood-2016-12-758979. https://pubmed.ncbi.nlm.nih.gov/28408464/
5. Yao, Xiaojuan, Chen, Ruiying, Chen, Hongting, Koleske, Anthony, Xiao, Xiao. 2024. Impact of Abl2/Arg deficiency on anxiety and depressive behaviors in mice. In Behavioural brain research, 468, 115022. doi:10.1016/j.bbr.2024.115022. https://pubmed.ncbi.nlm.nih.gov/38697301/
6. Liu, Yun, Shao, Chen, Zhu, Linqi, Cao, Hui, Shao, Shihe. 2018. High Expression of ABL2 Suppresses Apoptosis in Gastric Cancer. In Digestive diseases and sciences, 63, 2294-2300. doi:10.1007/s10620-018-5111-7. https://pubmed.ncbi.nlm.nih.gov/29767389/
7. Eadie, Laura N, Lagonik, Elias, Page, Elyse C, Hughes, Timothy P, White, Deborah L. . Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy. In Blood, 144, 1022-1026. doi:10.1182/blood.2024024776. https://pubmed.ncbi.nlm.nih.gov/38848536/
8. Xing, Quan-Tai, Qu, Chun-Mei, Wang, Gang. 2014. Overexpression of Abl2 predicts poor prognosis in hepatocellular carcinomas and is associated with cancer cell migration and invasion. In OncoTargets and therapy, 7, 881-5. doi:10.2147/OTT.S62348. https://pubmed.ncbi.nlm.nih.gov/24940071/
9. Salah, Eidarus, Ugochukwu, Emilie, Barr, Alastair J, Knapp, Stefan, Elkins, Jonathan M. 2011. Crystal structures of ABL-related gene (ABL2) in complex with imatinib, tozasertib (VX-680), and a type I inhibitor of the triazole carbothioamide class. In Journal of medicinal chemistry, 54, 2359-67. doi:10.1021/jm101506n. https://pubmed.ncbi.nlm.nih.gov/21417343/
10. van Outersterp, Inge, Tasian, Sarah K, Reichert, Caitlin E J, Boer, Judith M, den Boer, Monique L. . Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain. In Blood, 143, 2178-2189. doi:10.1182/blood.2023023120. https://pubmed.ncbi.nlm.nih.gov/38394665/
智鼠故事 
